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http:WHAT THIS PAPER ADDS
Infrainguinal open vascular procedures are particularly prone to surgical site infection. However, owing to the
steady advancement of endovascular treatments, the contemporary incidence of associated infections is largely
unknown. This study presents recent data on infectious complications and related risk factors after lower ex-
tremity open and endovascular revascularization on a national basis, thereby providing a means of assessing the
choice of treatment and likely outcomes for different patient categories.Objective: This population-based study aims to elucidate the incidence of healthcare-associated infections (HCAI)
and related risk factors in non-emergent, open and endovascular lower extremity vascular procedures.
Method: This was a retrospective analysis of prospectively collected data from the Swedish National Vascular
Surgery registry (Swedvasc), National Patient registry, and Cause of Death registry. A nationwide survey of all
postoperative infections among patients who have undergone non-emergent open and endovascular surgery for
lower extremity arterial disease between January 2005 to December 2010 (n ¼ 10,547) has been performed.
Data were retrieved from the National Vascular Surgery registry and cross-matched with the National Patient and
Cause of Death registries. The primary purpose of the study was to identify the rate of 30-day postoperative
infections and the associated risk factors for the different classes of lower extremity ischemia and operative
procedures.
Results: The study cohort included patients with claudication 27.0% (n ¼ 2,827) and critical limb ischemia (CLI),
consisting of rest pain 17.0% (n ¼ 1,835) and ulceration/gangrene 56.0% (n ¼ 5,885) undergoing endovascular
intervention (n ¼ 6,262; 59.0%), thromboendarterectomy (n ¼ 1,061; 10.0%), or bypass surgery (n ¼ 3,224;
31.0%). The total incidence of postoperative infection (<30-days) was 9.7% (n ¼ 1,019), including skin and soft
tissue infection (n ¼ 735; 6.9%), urinary tract infection (n ¼ 168; 1.6%), pneumonia (n ¼ 114; 1.1%), and sepsis
(n ¼ 91; 0.9%). In claudicants, the risk of infection was increased eightfold for bypass surgery compared with
endovascular intervention (odds ratio 8.4, 95% conﬁdence interval 5.0e14). Risk factors associated with infection
were degree of lower extremity ischemia, diabetes, renal insufﬁciency, and heart and lung disease (p < .05).
Conclusion: The postoperative rate of HCAI is associated with cardiovascular risk factors, operative method, and
degree of lower extremity ischemia. This may be of assistance when deciding on the type of operative procedure
for these patients.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Postoperative infections in vascular surgery are relatively
common complications with potentially grave conse-
quences.1,2 Infectious complications range from surgical
site infections (SSI), which can vary from superﬁcial
dermal infections (Szylagyi Grade I) to deep infections
involving arterial implants (Szylagyi Grade III), and can
directly affect the outcome of the operation and possiblyresponding author. A. Daryapeyma, Department of Vascular Sur-
arolinska Institute, Karolinska University Hospital, SE-171 76 Stock-
weden.
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//dx.doi.org/10.1016/j.ejvs.2014.02.003result in limb loss, urinary tract infections (UTI), pneu-
monia, or sepsis, causing considerable morbidity and
prolonged hospital length of stay.1 Infrainguinal open
procedures are particularly prone to SSI owing to the use
of groin incisions2 and an over-representation of diabetics
in the patient population.3,4 The steady advance of
percutaneous endovascular treatments has, by and large,
eliminated the risk of SSI in this patient category. How-
ever, owing to the ambulatory nature of these treatments
and varying follow-up regimens the incidence of associ-
ated infections is largely unknown.
The aim of this study was to evaluate the rate of
healthcare-associated infections (HCAI) and related risk
factors in patients treated for lower extremity arterial dis-
ease on a national basis, thereby providing a means of
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different patient categories.
METHOD
Study population
All patients who underwent non-emergent primary
infrainguinal surgery, open or endovascular, for lower ex-
tremity arterial disease between January 2005 and
December 2010 were included in the study. Patients with
secondary procedures, re-operations, or combined endo-
vascular and open surgery were excluded (n ¼ 2,763). Only
the ﬁrst surgery/intervention in the time span for each
patient was included in the analysis.
The study was approved by the local ethics committee.Data source
The Swedish National Registry for Vascular Surgery (Swed-
vasc), the Swedish National Patient Register (NPR), and the
Cause of Death Register were used as data sources to
collect information about patients who underwent either
open or endovascular lower extremity revascularization
during the study period. Using the subjects’ Civic Registra-
tion Numbers (CRN), which are registered at every contact
with the health authorities, facilitated the cross-matching of
data between different databases. Since 1994, when the
Swedvasc registry was established on a national basis, it has
been continuously updated and improved to include all
vascular procedures. Owing to the increasing number of
endovascular interventions the registry underwent a major
revision in May 2008 and became known as Swedvasc 2.0.
Thirty-four hospitals ranging from smaller county hospitals
to university hospitals covering all major population centres
have contributed to the database. The external validity of
Swedvasc has been shown to be >90.0%.5 All contact with
healthcare providers, whether hospitals or community care
providers, are registered in the NPR. According to a recent
report, the rate of missing main diagnosis codes was 0.9%
for hospital admissions and 10.0% for primary care con-
tacts.6 All deaths, including their causes, are registered in
the national Cause of Death Register.Study data
Data regarding demographics, presenting symptoms,
comorbidities, type of procedure, and follow-up visits at 30
days and 1 year were collected from Swedvasc. These data
were subsequently cross-matched with the NPR database
and the Cause of Death Registry to identify all postoperative
cases of infection within 30 days of the index operation.
Data regarding the 1-year amputation rate and 30-day
mortality were also obtained by cross-matching the three
databases.
Postoperative infections were classiﬁed according to the
International Classiﬁcation of Diseases (ICD-10-SE) diag-
nostic codes for skin and soft tissue infection, including
wound infection/abscess and graft infection (L031, L032,
L033, L038, L039, L08, L97, T814, T827), UTI (N10, N11, N12,N30, N39), pneumonia (J12eJ18), and sepsis (A40, A41).
Lower extremity amputation was deﬁned as major ampu-
tationdabove ankle (NGQ19; NFQ19).
The comorbidities included diabetes mellitus (all types),
hypertension, renal insufﬁciency (s-creatinine >150 mmol/
L), cerebrovascular disease (history of stroke, transient
ischemic attack, or major neurological deﬁcit), heart disease
(history of myocardial infarction, angina pectoris, heart
failure, or previous coronary intervention), lung disease
(chronic obstructive pulmonary disease), and smoking
(history of smoking within 5 years of index procedure). The
only discrepancy between Swedvasc 1.0 and 2.0 concerning
the deﬁnitions of the above risk factors was the omission of
atrial ﬁbrillation from heart disease in Swedvasc 2.0.
The patients were divided into three diagnostic cate-
gories based on the presenting lower extremity symptoms:
claudication, critical limb ischemia (CLI) (rest pain without
wound/gangrene), and ulceration/gangrene.
The operative methods were comprised of both open
surgical procedures and endovascular interventions. The
open surgical methods included groin thromboendarter-
ectomy (TEA), including the common femoral, profunda,
and proximal superﬁcial arteries and bypass surgery (vein or
synthetic grafts). The endovascular interventions included a
range of procedures from percutaneous transluminal an-
gioplasty to subintimal angioplasty and placement of
stents/stent-grafts. The guidelines for the administration of
prophylactic antibiotics in open procedures ranges nation-
wide from one to three doses of cloxacillin (2 g intrave-
nously [i.v.]) and in case of penicillin allergy, clindamycin
(600 mg i.v. three times). As there are no national or
regional guidelines pertaining to the administration of
prophylactic antibiotics for endovascular procedures, the
use of such prophylaxis remains discretionary. Hybrid cases
(open and endovascular) were excluded.
Statistical analysis
The database was prepared using SAS version 9.3 (SAS
Institute Inc., Cary, NC, USA). R version 2.14.2 (R Foundation
for Statistical Computing, Vienna, Austria), and package
mice version 2.12 [2] was used for statistical analyses and
generation of statistical output.
The primary purpose of the study was to identify the rate
of 30-day postoperative infections and the associated risk
factors for the different classes of lower extremity ischemia
and operative procedures. The secondary purpose of the
study was to identify any associations between post-
operative infections and 30-day mortality and amputation
within 1 year.
Data are presented as the number and proportion of
patients for each independent variable both as a total and
the proportion with an infection within 30 days.
The impact of the selected variables on all types of in-
fections within 30 days were analyzed using logistic
regression models adjusted for Swedvasc registry version
(Swedvasc 1.0 or 2.0), both with only the variables and
registry version as factors (univariate model), and with all
the selected variables and registry version (multivariate
Table 1. Patient characteristics and variables.
Characteristics Variables All patients
(n ¼ 10,547)
n (%)
Patients with
infection
(n ¼ 1,019)
n (% total
of each
variable)
Age group, y <60 684 (6.5) 64 (9.4)
60e69 2,267 (21.5) 190 (8.4)
70e79 3,552 (33.7) 348 (9.8)
>79 4,044 (38.3) 417 (10.3)
Gender Male 5,437 (51.6) 529 (9.7)
Female 5,110 (48.4) 490 (9.6)
Diagnosis Claudication 2,827 (26.8) 117 (4.1)
Other critical 1,835 (17.4) 138 (7.5)
Wound/
gangrene
5,885 (55.8) 764 (13.0)
Renal
insufﬁciency
Yes 1,378 (13.1) 184 (13.4)
No 8,944 (84.8) 812 (9.1)
Missing 225 (2.1) 23 (10.2)
Cerebrovascular
disease
Yes 1,619 (15.4) 179 (11.1)
No 8,383 (79.5) 780 (9.3)
Missing 545 (5.2) 60 (11.0)
Diabetes Yes 4,001 (37.9) 431 (10.8)
No 6,333 (60.0) 566 (8.9)
Missing 213 (2.0) 22 (10.3)
Hypertension Yes 7,316 (69.4) 708 (9.7)
No 2,729 (25.9) 249 (9.1)
Missing 502 (4.8) 62 (12.4)
Heart disease Yes 4,985 (47.3) 542 (10.9)
No 5,066 (48.0) 430 (8.5)
Missing 496 (4.7) 47 (9.5)
Lung disease Yes 1,453 (13.8) 185 (12.7)
No 8,654 (82.1) 785 (9.1)
Missing 440 (4.2) 49 (11.1)
Smoking Yes 3,217 (30.5) 294 (9.1)
No 5,259 (49.9) 507 (9.6)
Missing 2,071 (19.6) 218 (10.5)
Operative
method
Endovascular 6,262 (59.4) 490 (7.8)
TEA 1,061 (10.1) 99 (9.3)
Bypass 3,224 (30.6) 430 (13.3)
Operative
method,
claudication
patients
Endovascular 1,712 (16.2) 21 (1.2)
TEA 490 (4.6) 38 (7.8)
Bypass 625 (5.9) 58 (9.3)
Operative
method,
CLI patients
Endovascular 933 (8.8) 38 (4.1)
TEA 213 (2.0) 17 (8.9)
Bypass 689 (6.5) 83 (12.0)
Operative
method,
ulceration/
gangrene
patients
Endovascular 3,617 (34.3) 431 (11.9)
TEA 358 (3.4) 44 (12.3)
Bypass 1,910 (18.1) 289 (15.1)
Note. CLI ¼ critical limb ischemia; TEA ¼ thromboendarterectomy.
74 A. Daryapeyma et al.model). Differences based on type of procedure between
groups with varying degrees of lower extremity ischemia
were investigated by including an interaction term in the
multivariate model. Potential further interactions between
variables and type of procedure or degree of lower ex-
tremity ischemia were investigated by adding further
interaction terms. The impact of infection on amputation
within 1 year and death within 30 days was investigated in
logistic regression models with only infection and registry
version as factors, and with adjustment for all the selected
variables, including degree of lower extremity ischemia and
type of procedure.
To account for missing data in the variables, all analyses
were performed using multiple imputation with chained
equations,7 with the assumption that data were missing at
random, conditional on the selected variables and the
infection outcome. Five data sets were imputed, and ana-
lyses on individual data sets were pooled to give correct
conﬁdence intervals and p-values. The imputation was
based on all selected variables, 30-day infections, and
interaction between type of procedure and degree of lower
extremity ischemia, and performed separately for data from
Swedvasc 1.0 and Swedvasc 2.0. The results were checked
against complete case analyses, and sensitivity to the
assumption of missing randomness was investigated using
imputation with weighted estimated frequencies for the
missing variables.
Estimated odds ratios (OR) of amputation within 1 year
and death within 30 days were analyzed using univariate
and multivariate logistical regression analyses for patients
with and without 30-day infection and presented with 95%
conﬁdence intervals (CI) and p-values (p < .05 was
considered to be statistically signiﬁcant).
RESULTS
The study included 10,547 patients with lower extremity
arterial disease who underwent an elective infrainguinal
procedure (open or endovascular) during the speciﬁed
period. Patient characteristics are shown in Table 1. Median
age was 73 years (range 41e96 years). Men comprised
52.0% of the patients. The elderly dominated the cohort,
with 93.5% older than 60 years and 72.0% older than 70
years. The total annual number of procedures was evenly
distributed throughout the period (median 1,680; range
1,677e1,900).
The presenting symptoms based on the degree of lower
extremity ischemia were divided into claudication
(n ¼ 2,827; 27.0%) and CLI, consisting of rest pain
(n ¼ 1,835; 17.0%) and ulceration/gangrene (n ¼ 5,885;
56.0%). The treatment modalities consisted of endovascular
intervention (n ¼ 6,266; 59.0%), TEA (n ¼ 1,061; 10.0%),
and bypass surgery (n ¼ 3,224; 31.0%). The proportion of
endovascular procedures was 54.0% during the ﬁrst half of
the period (2005e08) and 66.0% during the second half
(2008e10).
The total incidence of postoperative infection (<30 days)
was 9.7% (n ¼ 1,019). These consisted of skin and soft
tissue infection (n ¼ 735; 6.9%), including SSI, UTI (n ¼ 168;1.6%), pneumonia (n ¼ 114; 1.1%), and sepsis (n ¼ 91;
0.9%). The crude rates of postoperative infection for each
diagnostic group and type of procedure are given in Table 1.
The incidence of postoperative infections according to the
degree of lower extremity ischemia was as follows: claudi-
cation, 4.1% (117/2,827); CLI, 7.5% (138/1,835); ulceration/
gangrene, 13.0% (764/5,885). The rates of postoperative
Table 2. Univariate and multivariate analysis of risk factors associated with postoperative healthcare-associated infections.
Characteristics Univariate model Multivariate model
OR (95% CI) P OR (95% CI) p
Diabetes 1.22 (1.07e1.39) .003 1.00 (0.87e1.16) .997
Hypertension 1.064 (0.91e1.23) .424 1.00 (0.86e1.17) .988
Renal insufﬁciency 1.55 (1.30e1.83) <.001 1.27 (1.06e1.53) .009
Cerebrovascular disease 1.22 (1.02e1.45) .029 1.11 (0.93e1.33) .252
Heart disease 1.32 (1.15e1.51) <.001 1.15 (1.00e1.33) .049
Lung disease 1.47 (1.24e1.74) <.001 1.37 (1.14e1.65) <.001
Smoking 0.93 (0.80e1.07) .281 0.91 (0.77e1.08) .280
Age 60e69 y vs. <60 y 0.88 (0.66e1.19) .411 0.83 (0.61e1.12) .224
Age 70e79 y vs. <60 y 1.05 (0.79e1.39) .741 0.86 (0.64e1.16) .320
Age >79 y vs. <60 y 1.11 (0.84e1.46) .457 0.79 (0.58e1.07) .120
Female gender 0.99 (0.87e1.12) .822 1.05 (0.92e1.21) .467
Note. OR ¼ odds ratio; CI ¼ conﬁdence interval.
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endovascular, 7.8% (490/6,262); TEA, 9.3% (99/1,061);
bypass surgery, 13.3% (430/3,224). Subgroup analysis of
bypass procedures based on type of graftdsynthetic or
autologous veindyielded the following: postoperative SSI
for vein grafts, 3.4% (73/2,146); postoperative SSI for syn-
thetic grafts, 2.0% (21/1,061); total HCAI within 30 days,
14.8% (317/2,146) for vein grafts and 10.6% (112/1,061) for
synthetic grafts. The risk factors associated with post-
operative infection at the p < .05 level, using univariate
analysis with multiple imputation were diabetes, renal
insufﬁciency, heart disease, lung disease, and cerebrovas-
cular disease (Table 2). In the multivariate model the in-
dependent predictors of infection were renal insufﬁciency
(OR 1.27; 95% CI 1.06e1.53, p ¼ .009) and lung disease (OR
1.37; 95% CI 1.14e1.65, p < .001), in addition to operative
method and degree of lower extremity ischaemia (Table 2).
The incidence of diabetes was 49.0% (2,822/5,761) in the
ulceration/gangrene group, compared with CLI 28% (503/
1,787) and claudication 24.0% (676/2,786). Thus, the inde-
pendent effect of diabetes was reduced when adjusted for
lower extremity ischemia classiﬁcation.
The OR for different types of operative method was seen
to differ signiﬁcantly between different classes of lowerTable 3. Univariate and multivariate analysis of degrees of lower extrem
healthcare-associated infections.
Characteristics Univariate
OR (95% CI)
p
CLI vs. claudication 1.89 (1.46e2.43) <.001
Gangrene vs. claudication 3.46 (2.83e4.23) <.001
Bypass vs. endovascular 1.86 (1.61e2.13) <.001
TEA vs. endovascular 1.20 (0.96e1.51) .107
Note. OR ¼ odds ratio; CI ¼ conﬁdence interval; CLI ¼ critical limb i
gangrene.extremity ischemia (p < .001). Using multivariate analysis,
TEA and bypass were compared with endovascular inter-
vention for each of the three diagnostic groups (Table 3).
The most notable differences were seen in claudicants and
CLI patients treated with TEA or bypass surgery as opposed
to endovascular intervention. In both claudicants and pa-
tients with CLI, TEA was associated with a higher rate of
infection compared with endovascular procedures (OR 6.7;
95% CI, 3.9e11.6, p < .001 and OR 2.0; 95% CI 1.1e3.7,
p < .001, respectively). The odds increase was even greater
when comparing bypass surgery to endovascular treatment
for claudicants (OR 8.4; 95% CI 5.0e14.0, p < .001) and CLI
patients (OR 3.4; 95% CI 2.3e5.1, p < .001).
The overall 1-year major amputation rate (6.2%, 544/
8,766) was signiﬁcantly associated with 30-day infection
(OR 2.25; 95% CI 1.78e2.83, p < .001). Patients without
postoperative infection had an amputation rate of 5.6%
(446/7,933), whereas patients with postoperative infection
had an amputation rate of 11.8% (98/833). Based on
multivariate analysis, there were also signiﬁcant associa-
tions with diabetes (OR 1.58; 95% CI 1.30e1.92, p < .001)
and cerebrovascular disease (OR 1.41; 95% CI 1.13e1.76).
In this analysis no association was shown for the type of
operative procedure.ity ischemia and operative method associated with postoperative
Characteristics Multivariate
OR (95% CI)
p
TEA 1.00 (0.55e1.82) .999
Bypass 1.34 (0.94e1.92) .105
Endovascular 3.30 (1.92e5.67) <.001
TEA 1.59 (1.00e2.52) .05
Bypass 1.70 (1.25e2.31) <.001
Endovascular 10.2 (6.52e15.99) <.001
Claudication 8.38 (5.03e13.95) <.001
CLI 3.41 (2.29e5.10) <.001
Gangrene 1.39 (1.18e1.65) <.001
Claudication 6.71 (3.89e11.55) <.001
CLI 2.03 (1.12e3.69) .019
Gangrene 1.04 (0.75e1.46) .808
schemia; TEA ¼ thromboendarterectomy; gangrene ¼ ulceration/
76 A. Daryapeyma et al.The overall 30-day mortality rate (2.7%, 284/10,547) was
associated with 30-d infection (OR 1.7; 95% CI 1.22e2.37,
p ¼ .002). The grade of severity of lower extremity ischemia
was associated with increased mortality: CLI versus claudi-
cation (OR 8.28; 95% CI 3.54e19.83, p < .001); ulceration/
gangrene versus claudication (OR 20.42; 95% CI 9.07e
45.94, p < .001). Patients without postoperative infection
had a mortality rate of 2.5% (241/9,528), whereas patients
with infection had a mortality rate of 4.2% (43/1,019). Using
multivariate analysis, the predictors of 30-day mortality
were degree of lower extremity ischemia, renal insufﬁ-
ciency, heart disease, and age (p < .001).DISCUSSION
Postoperative infectious complications after vascular sur-
gery represent a substantial burden of disease and have
considerable consequences for the community, as well for
the individual. Infections after infrainguinal procedures are
notoriously common and resistant to preventive mea-
sures.8e10
In this nationwide population-based study, the overall
rate of infections after non-emergent, open and endovas-
cular infrainguinal procedures, as well as associated risk
factors and the relative risks conferred by the presenting
lower extremity ischemia symptoms and choice of operative
method has been determined. It has been shown that both
the degree of ischemia and the presence of preoperative
comorbidities have a signiﬁcant impact on the rate of
postoperative HCAI and, by extension, on the rates of 30-
day mortality and 1-year amputation. The choice of opera-
tive method is also signiﬁcantly associated with the risk of
developing postoperative infectious complications.
The patient-speciﬁc predictors associated with post-
operative infection were diabetes mellitus, renal insufﬁ-
ciency, and heart and lung disease, which have been shown
in previous studies.11,12 In this study, the univariate analysis
showed a signiﬁcant association between diabetes and
postoperative infection, whereas in the multivariate ana-
lysisdwhich adjusted for, among other factors, lower ex-
tremity ischaemia classiﬁcationdthere was no signiﬁcant
interaction with infection. This apparent anomaly may be
explained by the over-representation of diabetic patients
with CLI and ulceration/gangrene. Renal insufﬁciency, and
heart and lung disease, however, remained as independent
predictors of infection, even when adjusted for degree of
lower extremity ischemia and operative method.
A signiﬁcant association between the degree of lower
extremity ischemia and the rate of infection has also been
shown. When adjusted for all other factors, not surprisingly
patients with ulceration/gangrene had the highest rate of
infection, followed by CLI and claudicants. This point
became more relevant when considering the interaction
with operative method.
Operative method was shown to be an independent
predictor of outcome in all three classes of lower extremity
ischemia. In comparing the open techniques with endo-
vascular interventions, it has been shown that claudicantstreated with TEA run a sevenfold higher risk of developing
HCAI than those treated with endovascular interventions.
However, the odds increase for patients with ulceration/
gangrene treated by bypass compared with endovascular
intervention is 39.0%. The odds are even higher for bypass
surgery compared with endovascular intervention. The
same pattern applies to patients with CLI. The putative
reasons for the seemingly higher rates of infection for pa-
tients with autologous vein grafts compared with those
with synthetic bypass grafts may partly be explained by the
almost exclusive use of synthetic grafts for above-knee by-
passes requiring less extensive skin incisions and dissection,
as opposed to vein grafts, which include distal bypasses, in a
cohort dominated by patients with ulceration/gangrene.
In this study the risk factors and outcomes of primary
procedures on patients requiring lower extremity revascu-
larization have been examined. By not including hybrid
procedures and re-operations, the overlap between
different operative methods and confounding factors for
postoperative infections has been minimized. The patients
not primarily included correspond to roughly 20.0% of all
infrainguinal procedures registered in Swedvasc during the
period under study. Arguably, this could lead to a selection
bias were it not for the fact that the excluded group, which
included re-operations and hybrid procedures, were drawn
from the same general population as the study group
without any other selection criteria. This is reﬂected in the
large proportion of patients with ulceration/gangrene
(56.0%) in the cohort. Owing to lack of consensus and inter-
hospital variations regarding the choice of procedure based
on patient characteristics and degree of lower extremity
ischemia it is not possible to make any categorical state-
ments regarding the choice of procedure for different pa-
tient categories. Endovascular interventions are generally
associated with fewer infectious complicationsd7.8%
compared with 9.3% (TEA) and 13.3% (bypass). There exists
a wide range of variation according to the degree of lower
extremity ischemia. The choice between a bypass operation
and endovascular treatment for a claudicant translates into
an eightfold increased risk of developing an HCAI if oper-
ated on with a bypass.
The Swedvasc database, along with NPR and the Cause of
Death Register, together with a relatively small and ho-
mogenous population, afford a unique opportunity for
charting the outcomes analyzed in this study. However, this
study has several weaknesses, which are primarily the result
of the retrospective design and the registries used for data
collection. Certain parameters, such as body mass index/
obesity,13 length of operation, and length of hospital stay,
were not included in the databases. The exact diagnostic
criteria for the various postoperative infections cannot be
speciﬁed, which can lead to a degree of ambiguity, partic-
ularly in the diagnosis of SSI, which would, ideally, require a
speciﬁc deﬁnition.14,15
The impact of HCAI on the patency of arterial procedures
was not further explored, as the main focus of the study
was on postoperative complications. Duplex veriﬁed
patency data in the aforementioned registries are
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mortality data is more reliable after cross-matching the
vascular registry with the National Patient and Cause of
Death registries.
The total incidence of postoperative HCAI in this study
(9.7%) is somewhat lower than the rates of SSI after lower
extremity revascularisation reported in other studies.8,16 It
is suspected that the main reason for this discrepancy is the
lack of a uniﬁed deﬁnition for SSI and a systematic under-
reporting of postoperative infections in outpatient care.
Compared with studies that have looked at HCAI after open
vascular surgery,1 the rate of infection in this study is
considerably higher, presumably owing to the chosen
cohort of infrainguinal procedures and the inclusion of pa-
tients with ulceration/gangrene.
In conclusion, the rate of infection within 30 days, both in
hospital and after discharge, for patients undergoing open
or endovascular revascularizations in a large population
based cohort has been determined. The signiﬁcant risk
factors for the development of postoperative infection, 30-
day mortality and 1-year amputation for this cohort have
also been identiﬁed. Furthermore, the effect of the inter-
action between different classes of lower extremity
ischemia and choice of operative method on postoperative
HCAI has been shown. This may be of help when deciding
on the type of procedure for patients with varying degrees
of lower extremity ischemia.
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